Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Public Health ; 13: 253, 2013 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-23517410

RESUMO

The Chemical Events Working Group of the Global Health Security Initiative has developed a flexible screening tool for chemicals that present a risk when accidentally or deliberately released into the atmosphere. The tool is generic, semi-quantitative, independent of site, situation and scenario, encompasses all chemical hazards (toxicity, flammability and reactivity), and can be easily and quickly implemented by non-subject matter experts using freely available, authoritative information. Public health practitioners and planners can use the screening tool to assist them in directing their activities in each of the five stages of the disaster management cycle.


Assuntos
Atmosfera/química , Vazamento de Resíduos Químicos , Terrorismo Químico , Planejamento em Desastres/organização & administração , Prioridades em Saúde/organização & administração , Monitoramento Ambiental , Saúde Global , Substâncias Perigosas/análise , Humanos , Medição de Risco/métodos
2.
Mycoses ; 54(4): 279-310, 2011 07.
Artigo em Inglês | MEDLINE | ID: mdl-21672038

RESUMO

Invasive Candida infections are important causes of morbidity and mortality in immunocompromised and hospitalised patients. This article provides the joint recommendations of the German-speaking Mycological Society (Deutschsprachige Mykologische Gesellschaft, DMyKG) and the Paul-Ehrlich-Society for Chemotherapy (PEG) for diagnosis and treatment of invasive and superficial Candida infections. The recommendations are based on published results of clinical trials, case-series and expert opinion using the evidence criteria set forth by the Infectious Diseases Society of America (IDSA). Key recommendations are summarised here: The cornerstone of diagnosis remains the detection of the organism by culture with identification of the isolate at the species level; in vitro susceptibility testing is mandatory for invasive isolates. Options for initial therapy of candidaemia and other invasive Candida infections in non-granulocytopenic patients include fluconazole or one of the three approved echinocandin compounds; liposomal amphotericin B and voriconazole are secondary alternatives because of their less favourable pharmacological properties. In granulocytopenic patients, an echinocandin or liposomal amphotericin B is recommended as initial therapy based on the fungicidal mode of action. Indwelling central venous catheters serve as a main source of infection independent of the pathogenesis of candidaemia in the individual patients and should be removed whenever feasible. Pre-existing immunosuppressive treatment, particularly by glucocorticosteroids, ought to be discontinued, if feasible, or reduced. The duration of treatment for uncomplicated candidaemia is 14 days following the first negative blood culture and resolution of all associated symptoms and findings. Ophthalmoscopy is recommended prior to the discontinuation of antifungal chemotherapy to rule out endophthalmitis or chorioretinitis. Beyond these key recommendations, this article provides detailed recommendations for specific disease entities, for antifungal treatment in paediatric patients as well as a comprehensive discussion of epidemiology, clinical presentation and emerging diagnostic options of invasive and superficial Candida infections.


Assuntos
Candida/isolamento & purificação , Candidíase/diagnóstico , Candidíase/tratamento farmacológico , Antifúngicos/uso terapêutico , Candida/classificação , Humanos , Técnicas Microbiológicas/métodos
4.
Med Mycol ; 48 Suppl 1: S88-97, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21067335

RESUMO

Filamentous fungi and yeasts are increasingly isolated from respiratory secretions of patients with cystic fibrosis (CF), and persistent fungal colonization of the airways of such patients is thought to exacerbate lung damage. While many independent studies have identified Aspergillus fumigatus complex as the principal colonizing fungus in CF, increased awareness of the role of fungi in CF pathology coupled with improved mycological culture and identification methods have resulted in a number of other fungi being isolated and reported from CF sputum samples, including A. terreus, members of the Pseudallescheria boydii/Scedosporium apiospermum complex, Exophiala dermatitidis, Paecilomyces and Penicillium species. However, the range of fungal pathogens isolated and the relative prevalence of individual species vary widely between reports from different geographical CF centres, and as yet no standardized method for the mycological examination of CF sputum samples has been adopted. Here, we examine the potential contribution of the mycological methods employed to examine CF respiratory secretions relative to the variability in the fungal biota reported. The role of direct microscopic examination of respiratory samples and the impact of the culture conditions used on the detection of specific fungal pathogens are addressed, and the potential significance of isolation of yeast species from CF patient airways is discussed.


Assuntos
Fibrose Cística/microbiologia , Fungos/isolamento & purificação , Pneumopatias Fúngicas/epidemiologia , Técnicas de Tipagem Micológica/normas , Escarro/microbiologia , Meios de Cultura , Fibrose Cística/epidemiologia , França , Fungos/classificação , Humanos , Pneumopatias Fúngicas/microbiologia , Técnicas Microbiológicas/métodos , Técnicas Microbiológicas/normas , Microscopia/métodos , Técnicas de Tipagem Micológica/métodos , Prevalência , Reino Unido
5.
Artigo em Alemão | MEDLINE | ID: mdl-20232269

RESUMO

Brain infections caused by fungi of the Pseudallescheria / Scedosporium-complex weeks or months after a near drowning event should be considered, since mortality rate is high and specific diagnostic methods are necessary for fungal detection. Voriconazole is the only authorised antimycotic drug available for the treatment of these infections in Germany, but other antimycotics may also be indicated for alternate or combined treatment strategies. Consultation of a specific reference laboratory is recommended in comparable relevant cases.


Assuntos
Antifúngicos/uso terapêutico , Infecções do Sistema Nervoso Central/tratamento farmacológico , Infecções do Sistema Nervoso Central/etiologia , Micoses/tratamento farmacológico , Micoses/etiologia , Afogamento Iminente/complicações , Pseudallescheria , Pirimidinas/uso terapêutico , Scedosporium , Triazóis/uso terapêutico , Adolescente , Adulto , Encéfalo/microbiologia , Infecções do Sistema Nervoso Central/microbiologia , Pré-Escolar , Feminino , Alemanha , Humanos , Masculino , Pessoa de Meia-Idade , Micoses/microbiologia , Afogamento Iminente/microbiologia , Voriconazol , Adulto Jovem
6.
J Gastroenterol ; 44(9): 944-51, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19551459

RESUMO

PURPOSE: The glucose hydrogen breath test (GHBT) is commonly used as a noninvasive test to diagnose small bowel bacterial overgrowth (SBBO) but its validity has been questioned. Our aim was to evaluate the lactose-[(13)C]ureide breath test (LUBT) to diagnose SBBO and to compare it with the GHBT, using cultures of intestinal aspirates as a gold standard. METHODS: In 22 patients with suspected SBBO (14 male, age range 18-73 years) aspirates were taken from the region of the ligament of Treitz under sterile conditions and cultured for bacterial growth. More than 10(6) colony-forming units/mL fluid or the presence of colonic flora was defined as culture positive (c+). After oral intake of 50 g glucose and 2 g of lactose-[(13)C]ureide, end-expiratory breath samples were obtained up to 120 min. The (13)C/(12)C ratio in breath CO(2) was determined by isotope ratio-mass spectrometry and hydrogen concentration in breath was analyzed electrochemically. RESULTS: After analyzing receiver operating characteristic curves of the LUBT results, total label recovery of >0.88% at 120 min was considered positive. The test had a sensitivity of 66.7% and a specificity of 100% to predict c+. In the GHBT, an increase of the signal of > or =12 ppm from baseline was considered positive. The sensitivity and specificity of the test were 41.7 and 44.4%, respectively. CONCLUSIONS: The new stable isotope-labeled LUBT has excellent specificity but suboptimal sensitivity. In contrast, the standard GHBT lacks both high sensitivity and specificity. The LUBT is superior to the GHBT for detecting SBBO.


Assuntos
Infecções Bacterianas/diagnóstico , Intestino Delgado/microbiologia , Lactose , Ureia/análogos & derivados , Adolescente , Adulto , Idoso , Testes Respiratórios/métodos , Feminino , Glucose , Humanos , Hidrogênio/metabolismo , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade
8.
Med Mycol ; 47(4): 359-70, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19031336

RESUMO

Scedosporium prolificans is a truly emerging fungal pathogen. It has only been recognized as a human pathogen for 22 years and has been related with numerous infections in immunocompromised and immunocompetent patients. A search for cases in the literature was performed and a database was constructed. Cases were reviewed in order to analyse the epidemiology and outcome of infection. A total of 162 cases were included. The median age of patients was 45 years (ranging from a few months to 81 years), and 102 (63%) infections were diagnosed in males. Risk factors for scedosporiosis were malignancy, 74/162 (45.7%), cystic fibrosis, 19/172 (11.7%), and solid organ transplantation 14/162 (8.6%). The most common clinical presentations were disseminated infection, 72/162 cases (44.4%), pulmonary mycosis, 47/162 (29%), and bone and joint infections, 17/162 (10.4%). All disseminated infections afflicted patents with underlying diseases, primarily haematological malignancies (57/72 [80%]). Blood cultures were positive in 70% of patients suffering from disseminated mycosis. Neutropenia, fever and cerebral symptoms were independently related to the development of disseminated infection whereas recovery from aplasia was associated with a reduced risk. The overall mortality was 46.9% but mortality rate was 87.5% in patients with disseminated disease. Survival was independently associated with surgical excision and recovery from aplasia. Antifungal treatments were not related to a reduced risk of death. Infections caused by S. prolificans are life threatening in susceptible patients, and can be considered a truly emerging disease. Infections are difficult to treat since it is a multi-resistant species. Multicenter studies are essential with the aim of developing and disseminating appropriate techniques and protocols to treat this mycosis.


Assuntos
Antifúngicos/uso terapêutico , Micoses/epidemiologia , Micoses/terapia , Scedosporium/isolamento & purificação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Micoses/microbiologia , Micoses/mortalidade , Fatores de Risco , Scedosporium/efeitos dos fármacos , Resultado do Tratamento , Adulto Jovem
9.
Mycoses ; 51 Suppl 3: 11-6, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18782237

RESUMO

Fungal infections caused by the members of the genera Pseudallescheria and/or Scedosporium are important complications in patients after near-drowning. As the taxonomy of Pseudallescheria and Scedosporium has been revised, clinical isolates from 11 patients, after near-drowning, previously identified as P. boydii or S. apiospermum had to be re-identified. S. apiospermum, now separated from P. boydii as a distinct species, was found most frequently (n = 8), while S. aurantiacum, recently described as new species and P. boydii were less common (n = 2 and n = 1, respectively). Three patients near-drowned during the Tsunami 2004 were infected by different species of the P. boydii complex. In vitro testing resulted in lowest minimal inhibitory concentration (MICs) for voriconazole (range 0.25-2.0 microg ml(-1)).


Assuntos
Micetoma/microbiologia , Afogamento Iminente/complicações , Pseudallescheria/classificação , Scedosporium/classificação , Adulto , Idoso , Antifúngicos/farmacologia , Encéfalo/microbiologia , Pré-Escolar , DNA Fúngico/análise , DNA Espaçador Ribossômico/análise , Feminino , Humanos , Lactente , Pulmão/microbiologia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Técnicas de Tipagem Micológica , Pseudallescheria/efeitos dos fármacos , Pseudallescheria/genética , Pseudallescheria/isolamento & purificação , Scedosporium/efeitos dos fármacos , Scedosporium/genética , Scedosporium/isolamento & purificação , Pele/microbiologia , Especificidade da Espécie
10.
Med Mycol ; 46(7): 675-84, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18608929

RESUMO

Candida albicans infections often occur during or shortly after antibacterial treatment. Phagocytosis by polymorphonuclear neutrophil granulocytes (PMN) is the most important primarily defence mechanism against C. albicans. Certain antibiotics such as some fluoroquinolones (FQ) are known to influence phagocyte functions. Thus, we investigated the influence of older and newer FQ on the phagocytosis and killing of C. albicans by human PMN paying special attention to CD11b expression of these cells as an indicator of the degree of their activation. In order to obtain comprehensive and comparable results we tested 13 FQ over a wide range of concentrations and in a time dependent manner in a standardized approach. When used at therapeutic concentrations, the FQ tested did not influence to a clinically significant degree the phagocytosis or the killing of C. albicans by human PMN and also not their activation. However, at high concentrations those FQ with cyclopropyl-moiety at position N1 showed increase in CD11b expression and diminished phagocytosis and oxidative burst.


Assuntos
Antibacterianos/farmacologia , Candida albicans/fisiologia , Fluoroquinolonas/farmacologia , Neutrófilos/efeitos dos fármacos , Fagocitose/efeitos dos fármacos , Adulto , Antígeno CD11b/metabolismo , Candida albicans/efeitos dos fármacos , Feminino , Regulação da Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Explosão Respiratória/efeitos dos fármacos , Adulto Jovem
11.
Med Mycol ; 44(4): 295-327, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16772225

RESUMO

Current knowledge on the opportunist Scedosporium apiospermum (teleomorph: Pseudallescheria boydii), generated over a period of more than 120 years, is reviewed. The natural environmental habitat of the fungus is unknown; nutrient-rich, brackish waters like river estuaria have been suggested. The fungus is strongly promoted by agricultural and particularly by industrial pollution.


Assuntos
Antifúngicos/uso terapêutico , Farmacorresistência Fúngica , Micetoma/tratamento farmacológico , Micetoma/fisiopatologia , Infecções Oportunistas/tratamento farmacológico , Scedosporium/patogenicidade , Adolescente , Adulto , Animais , Bovinos , Criança , Pré-Escolar , Cães , Cobaias , Humanos , Camundongos , Micetoma/epidemiologia , Micetoma/microbiologia , Infecções Oportunistas/epidemiologia , Infecções Oportunistas/microbiologia , Infecções Oportunistas/fisiopatologia , Scedosporium/classificação , Scedosporium/crescimento & desenvolvimento
12.
Childs Nerv Syst ; 22(2): 189-92, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15864705

RESUMO

RATIONALE: We report on a cerebral infection by Pseudallescheria boydii in a 21-month-old boy after a near-drowning episode. MRI revealed multiple (> 60) intracerebral abscesses. METHODS: The surgical therapy included CSF drainage and microsurgical resection of one abscess for microbiological diagnosis. Antimycotic therapy included terbinafine and intraventricular caspofungin in addition to voriconazole. RESULTS: Systemic side effects of chemotherapy were not observed. After placement of a ventriculoperitoneal shunt, the boy was transferred to a rehabilitation clinic and improved neurologically. After 20 months, MRI documented a continuing remission of the disease. CONCLUSION: Our case proves that an aggressive treatment should be undertaken and can be successful in CNS pseudallescheriasis.


Assuntos
Abscesso Encefálico/terapia , Encefalomielite/complicações , Encefalomielite/terapia , Micetoma/etiologia , Afogamento Iminente , Antibacterianos/uso terapêutico , Abscesso Encefálico/complicações , Abscesso Encefálico/microbiologia , Humanos , Lactente , Imageamento por Ressonância Magnética/métodos , Masculino , Neurocirurgia/métodos , Pseudallescheria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA